Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin AmyloidPablo García‐Pavía, Thibaud Damy, Erwan Donal et al.|New England Journal of Medicine|2023Cited by 233
A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cellsAubin Michalon, Jan Grimm|Nature Communications|2021Cited by 95